ABBEY PLC Preliminary Statement for the year ended 30 April 2016 The Group reports a profit of €61.5 million before taxation against a profit of €49.1 million in the previous year. After a tax charge of €12.0 million the Group made a profit of €49.5 million reflecting earnings per share of 229.81 cents. Group operating … Continued
Abbey plc (“Abbey” or the “Company”) Holding(s) in Company Abbey received notification on 24 March 2016 from Goldman Sachs Group, Inc that it has notifiable interest of 984,363 ordinary shares of €0.32 each in the capital of the Company which represents 4.57%* of the issued share capital of Abbey as at 29 March 2016. *This … Continued
ABBEY PLC INTERIM STATEMENT FOR THE SIX MONTHS ENDED 31 OCTOBER 2015 The Board of Abbey plc reports a profit before taxation of €29.68m which compares with a profit of €16.99m for the corresponding period last year. Profits at the operating level were €29.38m as compared to €16.53m at the half way stage last year. … Continued
Directors Declaration Pursuant to Schedule 2, Paragraph g of the AIM Rules and ESM Rules, Abbey plc (the “Company”) notifies the following in relation to Mr Nick Collins who was appointed a Director of the Company on 9 December 2015: In addition to companies within the Abbey Group xmrwallet.online> , Mr Collins is a director … Continued
Board Appointment Abbey plc (the “Company”) wish to announce the appointment of Mr Nick Collins as an executive Director of the Company. Mr Collins joined the Abbey Group in 1998 and is Managing Director of the Company’s Irish subsidiary doxycyclin 100 kaufen koupit-pilulky.com buy amoxicillin , Kingscroft Developments Limited. The Board of Company is delighted … Continued